Views & Analysis The promising future of RNA RNA technology-based therapeutics are a new and novel way to treat diseases.
News WuXi to build new $60m clinical and manufacturing plant WuXi Biologics has pledged to invest $60 million into a new US-based site to expand its clinical and manufacturing arm.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
